ARCHIVES

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

OCC to Take Over CIS Oct; Cost Sharing “Is Dead”

July 15, 1988

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

Interview with FDA’s Richard Pazdur

October 30, 2009

Academies Updates Guidelines on Stem Cell Research. NIH Begins New T-R01 Program.

September 19, 2008

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

Funding opportunities listed.

January 2, 2004